Latest News in the pharma Industry

Policy & Regulation

EC approves once-daily Olumiant tablets for treatment of adults with active RA

EC approves once-daily Olumiant tablets for treatment of adults with active RA

14 Feb 2017

Baricitinib, marketed as Olumiant, is the first JAK inhibitor approved to treat RA in the EU.

Read more 
Appeals Court grants stay of permanent injunction for Praluent during appeals process

Appeals Court grants stay of permanent injunction for Praluent during appeals process

9 Feb 2017

Praluent continues to be available to patients in the US.

Read more 
Lilly's Trulicity label updated to include use in combination with basal insulin for adults with type 2 diabetes

Lilly's Trulicity label updated to include use in combination with basal insulin for adults with type 2 diabetes

8 Feb 2017

Trulicity is a once-weekly glucagon-like peptide-1 (GLP-1) receptor agonist injectable prescription medicine.

Read more 
FDA approves first new treatment in more than a decade for secondary HPT in adults on hemodialysis

FDA approves first new treatment in more than a decade for secondary HPT in adults on hemodialysis

8 Feb 2017

Intravenous administration puts delivery in hands of healthcare provider.

Read more 
Amgen's Repatha significantly reduced the risk of cardiovascular events in FOURIER outcomes study

Amgen's Repatha significantly reduced the risk of cardiovascular events in FOURIER outcomes study

6 Feb 2017

Landmark Repatha cardiovascular outcomes study meets primary and key secondary endpoint.

Read more 
FDA accepts two sBLAs for Merck's Keytruda for metastatic urothelial cancer

FDA accepts two sBLAs for Merck's Keytruda for metastatic urothelial cancer

5 Feb 2017

Keytruda also receives Breakthrough Therapy Designation for second-line treatment.

Read more 
FDA approves BMS's Opdivo for bladder cancer

FDA approves BMS's Opdivo for bladder cancer

5 Feb 2017

Opdivo has now been approved in six tumour types in just over 2 years.

Read more 
Merck gets the thumbs up in Europe for Keytruda to treat patients with metastatic NSCLC

Merck gets the thumbs up in Europe for Keytruda to treat patients with metastatic NSCLC

2 Feb 2017

First anti-PD-1 therapy approved in Europe for previously untreated patients with metastatic NSCLC.

Read more 
EPO upholds decision regarding Sprycel

EPO upholds decision regarding Sprycel

1 Feb 2017

Patent found to be invalid.

Read more 
Sanofi's Xyzal Allergy 24HR approved for OTC use in the US

Sanofi's Xyzal Allergy 24HR approved for OTC use in the US

1 Feb 2017

Xyzal is an oral antihistamine with a proven 24-hour effect.

Read more 
Novartis' Votubia receives EU approval to treat refractory partial-onset seizures in patients with TSC

Novartis' Votubia receives EU approval to treat refractory partial-onset seizures in patients with TSC

31 Jan 2017

Decision marks the third TSC-related indication for Votubia in the EU.

Read more 
Mylan wins US District Court ruling related to Copaxone 40 mg/mL patents

Mylan wins US District Court ruling related to Copaxone 40 mg/mL patents

31 Jan 2017

Patents in question invalidated based on obviousness.

Read more